Broccoli chemical could tame autism symptoms, small trial hopes

NCT ID NCT02677051

Ongoing Symptom relief Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 2 trial tests whether sulforaphane, a compound found in broccoli, can improve core symptoms of autism. 48 males aged 13-30 with autism will receive either sulforaphane or a placebo for several weeks. Researchers will measure changes in behavior and social responsiveness using standard scales.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Sulforaphane (a compound from broccoli and other cruciferous vegetables)
What this could lead to: If it works, this could point toward a dietary supplement that eases core autism symptoms like social interaction and behavior.
What could go wrong: This is a small, early-phase trial with only 48 males, so results may not apply to everyone. Sulforaphane may cause no improvement or side effects like changes in liver or kidney function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder pervasive developmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM AUTISM SPECTRUM DISORDER AUTISTIC BEHAVIOR AUTISTIC DISORDER

Contacts and locations

Locations

Rutgers University - Staged Research Building

Piscataway, New Jersey, 08854, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.